In humans, plasma DPP-4 activity is higher in patients with non-alcoholic fatty liver disease irrespective of their glucose tolerance, whereas it was not elevated in patients with T2DM in whom liver disease had been excluded (84). Here, DPP4 is linked to liver disorder.